ISBERVIO Trademark
Trademark Overview
On Thursday, April 25, 2024, a trademark application was filed for ISBERVIO with the United States Patent and Trademark Office. The USPTO has given the ISBERVIO trademark a serial number of 98519052. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Thursday, November 14, 2024. This trademark is owned by Celgene Corporation. The ISBERVIO trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical and biological preparations for human use.
General Information
Serial Number | 98519052 |
Word Mark | ISBERVIO |
Filing Date | Thursday, April 25, 2024 |
Status | 641 - NON-FINAL ACTION - MAILED |
Status Date | Thursday, November 14, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
Goods and Services | Pharmaceutical and biological preparations for human use. |
Classification Information
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, April 25, 2024 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | Celgene Corporation |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Princeton, NJ 08543 |
Trademark Events
Event Date | Event Description |
Thursday, April 25, 2024 | NEW APPLICATION ENTERED |
Thursday, October 17, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Wednesday, November 6, 2024 | ASSIGNED TO EXAMINER |
Thursday, November 14, 2024 | NON-FINAL ACTION WRITTEN |
Thursday, November 14, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Thursday, November 14, 2024 | NON-FINAL ACTION E-MAILED |